Device
Drug Eluting Coronary Stent
Drug Eluting Coronary Stent is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph phase_4
1
25%
Ph not_applicable
2
50%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_4
Clinical Investigation for Everolimus Drug Eluting Stent
NCT06769217
completedphase_2
Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis
NCT00369356
completednot_applicable
V-Flex Plus PTX Drug Eluting Coronary Stent
NCT00225693
completednot_applicable
In Stent ELUTES Study
NCT00225680
Clinical Trials (4)
Showing 4 of 4 trials
NCT06769217Phase 4
Clinical Investigation for Everolimus Drug Eluting Stent
NCT00369356Phase 2
Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis
NCT00225693Not Applicable
V-Flex Plus PTX Drug Eluting Coronary Stent
NCT00225680Not Applicable
In Stent ELUTES Study
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4